Stock ANZU ANZU SPEC
Add to a list
To use this feature you must be a member
Log inSign up

ANZU SPEC

Equities

ANZU

US03737A1016

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-01 pm EDT 		5-day change 1st Jan Change
4.43 USD +4.24% Intraday chart for ANZU SPEC -11.04% -36.85%
2023 Anzu Special Acquisition Corp I(NasdaqCM:ANZU) dropped from NASDAQ Composite Index CI
2023 Envoy Medical Corporation completed the acquisition of Anzu Special Acquisition Corp I from Anzu SPAC GP I LLC and others in a reverse merger transaction. CI

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration

Latest news about ANZU SPEC

Anzu Special Acquisition Corp I(NasdaqCM:ANZU) dropped from NASDAQ Composite Index CI
Envoy Medical Corporation completed the acquisition of Anzu Special Acquisition Corp I from Anzu SPAC GP I LLC and others in a reverse merger transaction. CI
Anzu Special Acquisition Approves Business Combination With Envoy Medical MT
Anzu Special Acquisition Corp I Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Anzu Special Acquisition Corp I Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Anzu Special Acquisition Corp I Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Anzu Special Acquisition Corp I Auditor Raises 'Going Concern' Doubt CI
Envoy Medical Corporation entered into a letter of intent to acquire Anzu Special Acquisition Corp I in a reverse merger transaction for approximately $150 million. CI
Anzu Special Acquisition Corp I Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Anzu Special Acquisition Corp I Appoints Daniel J. Hirsch as Chief Financial Officer CI
Anzu Special Acquisition Corp I Announces Management Changes CI
Anzu Special Acquisition Corp I Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Anzu Special Acquisition Corp I Announces Executive Changes CI
Anzu Special Acquisition Corp I Announces the Resignation of John W. Joy as Chief Financial Officer CI
Anzu Special Acquisition Corp I Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Anzu Special Acquisition Corp I Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Anzu Special Acquisition Corp I Auditor Raises 'Going Concern' Doubt CI
Anzu Special Acquisition Corp I Signs up to $120 Million of Equity Forward-Purchase Agreements MT
Certain Class B Common Stock of Anzu Special Acquisition Corp I are subject to a Lock-Up Agreement Ending on 30-AUG-2021. CI
Anzu Special Acquisition Corp I(NasdaqCM:ANZU) added to NASDAQ Composite Index CI
Anzu Special Acquisition Corp I has completed an IPO in the amount of $420 million. CI
Anzu Special Acquisition Corp I announced that it has received $12.4 million in funding from Anzu SPAC GP I LLC CI
Anzu Special Acquisition Corp I has filed an IPO in the amount of $250 million. CI
Anzu Special Acquisition Corp I announced that it expects to receive $9 million in funding from Anzu SPAC GP I LLC CI

Chart ANZU SPEC

Chart ANZU SPEC
More charts

Company Profile

Anzu Special Acquisition Corp I is a blank check company. The Company is created for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company focuses on transformative technologies for industrial applications. The Company has no operations and has not generated revenues.
Sector
-
More about the company

Income Statement Evolution

More financial data
  1. Stock Market
  2. Equities
  3. ANZU Stock
  4. News ANZU SPEC
  5. Anzu Special Acquisition Approves Business Combination With Envoy Medical